vs
Side-by-side financial comparison of Arbutus Biopharma Corp (ABUS) and La Rosa Holdings Corp. (LRHC). Click either name above to swap in a different company.
La Rosa Holdings Corp. is the larger business by last-quarter revenue ($20.2M vs $10.7M, roughly 1.9× Arbutus Biopharma Corp). Arbutus Biopharma Corp runs the higher net margin — 23.5% vs -27.4%, a 50.9% gap on every dollar of revenue. On growth, Arbutus Biopharma Corp posted the faster year-over-year revenue change (522.2% vs 3.2%). Over the past eight quarters, La Rosa Holdings Corp.'s revenue compounded faster (72.5% CAGR vs -13.2%).
Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection.
V. La Rosa and Sons Macaroni Company was founded in 1914 by Vincenzo La Rosa, a Sicilian immigrant. The company eventually became one of the largest regional brands in the United States producing over 40 varieties of pasta.
ABUS vs LRHC — Head-to-Head
Income Statement — Q2 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $10.7M | $20.2M |
| Net Profit | $2.5M | $-5.5M |
| Gross Margin | — | 8.4% |
| Operating Margin | 13.9% | -24.7% |
| Net Margin | 23.5% | -27.4% |
| Revenue YoY | 522.2% | 3.2% |
| Net Profit YoY | 112.7% | -125.7% |
| EPS (diluted) | $0.01 | $-5.44 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | — | $20.2M | ||
| Q2 25 | $10.7M | $23.2M | ||
| Q1 25 | — | $17.5M | ||
| Q4 24 | — | $17.7M | ||
| Q3 24 | — | $19.6M | ||
| Q2 24 | — | $19.1M | ||
| Q1 24 | — | $13.1M | ||
| Q4 23 | $2.1M | — |
| Q3 25 | — | $-5.5M | ||
| Q2 25 | $2.5M | $78.4M | ||
| Q1 25 | — | $-95.7M | ||
| Q4 24 | — | $-5.1M | ||
| Q3 24 | — | $-2.5M | ||
| Q2 24 | — | $-2.3M | ||
| Q1 24 | — | $-4.6M | ||
| Q4 23 | — | — |
| Q3 25 | — | 8.4% | ||
| Q2 25 | — | 8.0% | ||
| Q1 25 | — | 8.8% | ||
| Q4 24 | — | 8.9% | ||
| Q3 24 | — | 8.3% | ||
| Q2 24 | — | 8.3% | ||
| Q1 24 | — | 8.9% | ||
| Q4 23 | — | — |
| Q3 25 | — | -24.7% | ||
| Q2 25 | 13.9% | -10.6% | ||
| Q1 25 | — | -26.7% | ||
| Q4 24 | — | -17.1% | ||
| Q3 24 | — | -8.9% | ||
| Q2 24 | — | -9.7% | ||
| Q1 24 | — | -35.0% | ||
| Q4 23 | -967.2% | — |
| Q3 25 | — | -27.4% | ||
| Q2 25 | 23.5% | 337.8% | ||
| Q1 25 | — | -546.5% | ||
| Q4 24 | — | -28.7% | ||
| Q3 24 | — | -12.5% | ||
| Q2 24 | — | -12.2% | ||
| Q1 24 | — | -35.1% | ||
| Q4 23 | — | — |
| Q3 25 | — | $-5.44 | ||
| Q2 25 | $0.01 | $15.25 | ||
| Q1 25 | — | $-5.86 | ||
| Q4 24 | — | $28.54 | ||
| Q3 24 | — | $-16.49 | ||
| Q2 24 | — | $-12.49 | ||
| Q1 24 | — | $-0.35 | ||
| Q4 23 | $-0.12 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $37.4M | $4.0M |
| Total DebtLower is stronger | $0 | $642.8K |
| Stockholders' EquityBook value | $83.0M | $1.6M |
| Total Assets | $103.3M | $21.7M |
| Debt / EquityLower = less leverage | 0.00× | 0.41× |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $4.0M | ||
| Q2 25 | $37.4M | $5.1M | ||
| Q1 25 | — | $2.9M | ||
| Q4 24 | — | $1.4M | ||
| Q3 24 | — | $1.8M | ||
| Q2 24 | — | $1.6M | ||
| Q1 24 | — | $1.1M | ||
| Q4 23 | $126.0M | — |
| Q3 25 | — | $642.8K | ||
| Q2 25 | $0 | $644.3K | ||
| Q1 25 | — | $645.9K | ||
| Q4 24 | — | $647.6K | ||
| Q3 24 | — | $649.2K | ||
| Q2 24 | — | $650.8K | ||
| Q1 24 | — | $652.4K | ||
| Q4 23 | $0 | — |
| Q3 25 | — | $1.6M | ||
| Q2 25 | $83.0M | $3.4M | ||
| Q1 25 | — | $-87.5M | ||
| Q4 24 | — | $2.6M | ||
| Q3 24 | — | $5.0M | ||
| Q2 24 | — | $4.7M | ||
| Q1 24 | — | $5.6M | ||
| Q4 23 | $106.0M | — |
| Q3 25 | — | $21.7M | ||
| Q2 25 | $103.3M | $22.9M | ||
| Q1 25 | — | $21.0M | ||
| Q4 24 | — | $19.4M | ||
| Q3 24 | — | $19.7M | ||
| Q2 24 | — | $18.7M | ||
| Q1 24 | — | $16.3M | ||
| Q4 23 | $144.4M | — |
| Q3 25 | — | 0.41× | ||
| Q2 25 | 0.00× | 0.19× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.25× | ||
| Q3 24 | — | 0.13× | ||
| Q2 24 | — | 0.14× | ||
| Q1 24 | — | 0.12× | ||
| Q4 23 | 0.00× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-15.7M | $-1.3M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | -6.24× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $-1.3M | ||
| Q2 25 | $-15.7M | $-1.4M | ||
| Q1 25 | — | $-3.5M | ||
| Q4 24 | — | $-1.1M | ||
| Q3 24 | — | $-591.6K | ||
| Q2 24 | — | $-803.1K | ||
| Q1 24 | — | $-538.3K | ||
| Q4 23 | $-17.3M | — |
| Q3 25 | — | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | 0.0% | — |
| Q3 25 | — | — | ||
| Q2 25 | -6.24× | -0.02× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABUS
Segment breakdown not available.
LRHC
| Real Estate Residential Brokerage Services | $16.8M | 83% |
| Transferred Over Time | $3.5M | 17% |
